Chávez PI; Aguilar RM; Cardoso GE; Álvarez PR

Language: Spanish
References: 13
Page: 212-220
PDF size: 139.53 Kb.

ABSTRACT

Introduction: macular edema is the most common cause of decreasing central visual acuity in patients with diabetic retinopathy; its origin is multifactorial. Central visual loss depends on retinal exudation and duration of the disease.
Objective: to reflect changes in the microperimetry after the use of triamcinolone acetonide injection in a patient with moderate non-proliferative diabetic retinopathy and macular edema clinically significant.
Clinical case: a patient with macular edema clinically significant associated with moderate non-proliferative diabetic retinopathy was evaluated through visual acuity test with best correction, biomiscroscopy of the anterior and posterior segment, indirect ophthalmoscopy, tonometry, microperimetry, automatic protocol to the macula of 12 degrees, 45 macular points was used. Eyeground examination and biomiscroscopy of the posterior segment showed intraretinal rounded bleeding in four quadrants, beaded venae in a quadrant, intraretinal microvascular abnormalities in two quadrants, thick and tortuous vessels, macula with hard exudate in posterior pole and microaneurysms outside of the foveolar avascular zone, in circinate forms, and scattered microhemorrhagia.
Conclusions: the patient was treated with focal macular photocoagulation and intravitreal triamcinolone acetonide injection; visual acuity improved so as the parameters in microperimetry over a period of a month.

REFERENCES

1. Midena E. Perimetry and the fundus: an Introduction to Microperimetry. New Jersey: SLACK Incomporated; 2007.

2. Midena E. Microperimetría. Arch Soc Esp Oftalmol. 2006; 81(4):183-6.

3. Shah VA, Chalam KV. Values for macular perimetry using the MP-1 microperimeter in normal subjects. Ophthalmic Res. 2009; 41(1):9-13.

4. Vujosevic S, Pilotto E, Bottega E, Benetti E, Cavarzeran F, Midena E, et al. Retinal fixation impairment in diabetic macular edema. Retina. 2008; 28(10):1443-50.

5. Rohrschneider K, Bultmann S, Springer C. Use of fundus perimetry (microperimetry) to quantify macular sensitivity. Prog Retin Eye Res. 2008; 27(5):536-48.

6. Abraldes MJ, Fernández M, Gómez Ulla F. Intravitreal Triamcinolone in Diabetic Retinopathy. Current Diabetes Reviews. 2009; 5(1):18-25.

7. Ramos López M, Aranda H, Rodríguez Rodríguez V, Hernández Silva JR, Eguias Martínez F. Uso de triamcinolona intravítrea en edema macular del diabético. Rev Cubana oftalmol. 2007; 20(2):45-53.

8. Cabrera F. Actualización en el diagnóstico y tratamiento del edema macular diabético. Arch Soc Canar Octal. 2005; 16:69-82.

9. Pareja Ríos A, Serrano García M, Quijada Fumero E, Cabrera López F, Abreu Reyes P, Cardona Guerra P, et al. Protocolo para el tratamiento de la Retinopatía Diabética. Arch Soc Canar Oftal [Internet]. 2007 [citado 12 dic 2011]; 18(2):[aprox. 9 p.]. Disponible en: http://www.oftalmo.com/sco/revista-18/18sco02.htm

10. Senturk F, Ozdemir H, Karacorlu M, Karacorlu SA, Uysal O. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion. Retina. 2010; 30(8):1254-61.

11. Kameda T, Nishijima K, Unoki N, Sakamoto A, Hayashi H, Oh H Kita M, et al. Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2011; 249(1):3-9.

12. Roman D, Stefan S, Christian S, Christian P, Schmidt Erfurth U. Changes in macular sensitivity after reduced fluence photodynamic therapy combined with intravitreal triamcinolone. Acta Ophthalmological. 2011; 89(2):166-171.

13. Gómez Ulla F, Basauri E, Arias L, Martínez Sanz F. Manejo de las inyecciones intravítreas. Arch Soc Esp Oftalmol [Internet]. 2009 [citado 12 dic 2011]; 84(8):[aprox. 9 p.]. Disponible en: http://scielo.isciii.es/scielo.php?pid=S0365-66912009000800003&script=sci_arttext